title: On the Discovery of TOR As the Target of Rapamycin.
authors.affiliation: Departments of Molecular Genetics and Microbiology (MGM), Pharmacology and Cancer Biology, and Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.|Tri-Institutional (Duke, UNC, NC State) Molecular Mycology and Pathogenesis Training Program (Tri-I MMPTP), Duke University Medical Center, Durham, North Carolina, United States of America.
authors.forename: Joseph
authors.initials: J
authors.lastname: Heitman
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D058570:TOR Serine-Threonine Kinases / Q000187:drug effects*; D019737:Transplants
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus